SCHEMBL7036714

SCHEMBL7036714

CCCCCCOC(=O)N[C@@H](CNC(=O)c1ccc(OCCNC(=O)NCc2cccnc2)cc1O)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.49
TSHR P16473 1/20 0.42
FES P07332 1/20 0.41
RET P07949 1/20 0.41
MARK3 P27448 1/20 0.41
TYK2 P29597 1/20 0.41
FLT4 P35916 1/20 0.41
SYK P43405 1/20 0.41
CLK2 P49760 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
ITGB3 P05106 2/20 0.41
ITGA2B P08514 1/20 0.41
GPR132 Q9UNW8 4/20 0.41
FAAH O00519 2/20 0.40
PLG P00747 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
CTSK P43235 1/20 0.39
ITGAV P06756 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7036984 1.00 NAMPT (0.49) NAMPTTSHRFESRETMARK3
SCHEMBL7030493 0.98 NAMPT (0.51) NAMPTTSHRFESRETMARK3
SCHEMBL7035254 0.94 NAMPT (0.52) NAMPTTSHRFESRETMARK3
SCHEMBL7035562 0.92 NAMPT (0.53) NAMPTTSHRFESRETMARK3
SCHEMBL7036473 0.92 ITGB3 (0.45) ITGB3ITGA2BITGAVITGB1ITGA4
SCHEMBL7036103 0.92 ITGB3 (0.45) ITGB3ITGA2BITGAVITGB1ITGA4
SCHEMBL7032247 0.91 ITGB3 (0.46) NAMPTITGB3ITGA2BALDH1A1LMNA
SCHEMBL7030930 0.91 ITGB3 (0.46) NAMPTITGB3ITGA2BALDH1A1LMNA
SCHEMBL7393007 0.91 ITGB3 (0.47) NAMPTITGB3ITGA2BALDH1A1LMNA
SCHEMBL7033889 0.90 NAMPT (0.56) NAMPTFESRETMARK3TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors ASGR1, TEK, APLNR NAMPT 566/4885TSHR 1206/4885FES 4541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.